±èÄ¡°æ

±èÄ¡°æ

±èÄ¡°æ ±³¼öÀÇ Áø·á½Ã°£Ç¥ Áø·á¿¹¾à

Áø·á°ú/¼¾ÅÍ ¿ù È­ ¼ö ¸ñ ±Ý Åä Àü¹®Áø·á°ú¸ñ
½Å°æ°ú
¿ÀÀü
¿ÀÈÄ
-
¿ÀÀü
- - ³úÁ¹Áß, ³ú°æ»ö, Ç÷°ü¼º Ä¡¸Å, ³úÇ÷°ü Áúȯ, ¾îÁö·¯¿òÁõ, °íÇ÷¾Ð³úº´Áõ
³ú½Å°æ¼¾ÅÍ
¿ÀÀü
- -
¿ÀÀü
- - ³úÁ¹Áß, ³ú°æ»ö, Ç÷°ü¼º Ä¡¸Å, ³úÇ÷°ü Áúȯ, ¾îÁö·¯¿òÁõ, °íÇ÷¾Ð³úº´Áõ

±èÄ¡°æ ±³¼öÀÇ »ó¼¼Á¤º¸

ÇзÂ

more
  • 1999 .03 .01 ~  2005 .02 .28 :  ¼­¿ï´ëÇб³ ÀÇ°ú´ëÇÐ ÀÇÇаú ÀÇÇлç
  • 2009 .03 .01 ~  2013 .02 .28 :  ¼­¿ï´ëÇб³ ÀÇ°ú´ëÇÐ ³ú½Å°æ°úÇÐ ¼®»ç
  • 2013 .03 .01 ~  2016 .02 .28 :  ¼­¿ï´ëÇб³ ÀÇ°ú´ëÇÐ ³ú½Å°æ°úÇÐ ¹Ú»ç

°æ·Â

more
  • 2005 .03 .01 ~  2006 .02 .28 :  ¼­¿ï´ëÇб³º´¿ø ÀÎÅÏ
  • 2006 .03 .01 ~  2010 .02 .28 :  ¼­¿ï´ëÇб³º´¿ø ½Å°æ°ú ·¹Áö´øÆ®
  • 2010 .04 .19 ~  2013 .04 .18 :  º¸°Çº¹ÁöºÎ Áß¾ÓÁ¤½Åº¸°Ç»ç¾÷´Ü °øÁߺ¸°ÇÀÇ
  • 2013 .05 .01 ~  2015 .04 .30 :  ¼­¿ï´ëÇб³º´¿ø ½Å°æ°ú ÀÓ»ó°­»ç
  • 2015 .05 .01 ~  2016 .02 .29 :  ¼­¿ï´ëÇб³º´¿ø ÀÇ»ý¸í¿¬±¸¿ø ¿¬±¸°­»ç
  • 2015 .08 .01 ~  2016 .02 .28 :  Research Fellow, Calgary Stroke Program, University of Calgary (ij³ª´Ù)
  • 2016 .03 .01 ~  2018 .08 .31 :  °í·Á´ëÇб³ ±¸·Îº´¿ø ½Å°æ°ú ÀÓ»óÁ¶±³¼ö
  • 2018 .09 .01 ~  2020 .02 .29 :  °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ (°í·Á´ëÇб³ ±¸·Îº´¿ø) ½Å°æ°ú Á¶±³¼ö
  • 2020 .03 .01 ~   :  °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ (°í·Á´ëÇб³ ±¸·Îº´¿ø) ½Å°æ°ú ºÎ±³¼ö

¼ö»ó³»¿ª

more
  • 2019 .11 .11 ~  2019 .11 .11 :  2nd KU International Medical Student Research Conference Best Poster Presentation Award (Áöµµ±³¼ö)
  • 2019 .10 .19 ~  2019 .10 .19 :  ´ëÇѽŰæÃÊÀ½ÆÄÇÐȸ Ãß°èÇмú´ëȸ 2019 ¿ì¼ö±¸¿¬»ó
  • 2018 .11 .09 ~  2018 .11 .09 :  1st KU International Medical Student Research Conference Best Presentation Award (Áöµµ±³¼ö)
  • 2018 .01 .15 ~  2018 .01 .15 :  À¯´ç±â³ä»ç¾÷ȸ Çмú»ó
  • 2017 .10 .30 ~  2017 .10 .30 :  Á¦1ȸ È£ÀÇÇмúÁ¦ ¿ì¼ö»ó (Áöµµ±³¼ö)
  • 2015 .11 .13 ~  2015 .11 .13 :  SK ÀþÀº ¿¬±¸ÀÚ»ó
  • 2015 .02 .11 ~  2015 .02 .11 :  Travel Award for Junior Investigators in International Stroke Conference
  • 2014 .07 .17 ~  2014 .07 .17 :  Á¦46ȸ º¸°ÇÀåÇÐȸ Çмú»ó

ÇÐȸȰµ¿

more
  • 2006 .03 .01 ~   :  ´ëÇѽŰæ°úÇÐȸ (Á¤È¸¿ø)
  • 2008 .03 .01 ~   :  ´ëÇѳúÁ¹ÁßÇÐȸ (Á¤È¸¿ø)
  • 2009 .03 .01 ~   :  American Heart Association (professional member)
  • 2013 .03 .01 ~   :  ´ëÇÑÁßȯÀÚÀÇÇÐȸ (Æò»ýȸ¿ø)
  • 2013 .03 .01 ~   :  ´ëÇѽŰæÁýÁßÄ¡·áÇÐȸ (À繫°£»ç)
  • 2015 .03 .01 ~   :  European Stroke Organisation
  • 2016 .03 .01 ~   :  ´ëÇѽŰæÃÊÀ½ÆÄÇÐȸ (Ãѹ«°£»ç)
  • 2017 .05 .01 ~   :  Çѱ¹³úÁ¹ÁßÀÇÇבּ¸¿ø (ÀÌ»ç)
  • 2018 .02 .01 ~   :  Çѱ¹»ýüÀç·áÇÐȸ (ÇмúÀ§¿ø)
  • 2018 .05 .01 ~   :  World Stroke Organization
  • 2018 .11 .01 ~   :  ´ëÇÑ°íÇ÷¾ÐÇÐȸ (Æò»ýȸ¿ø)
  • 2020 .01 .01 ~   :  ´ëÇÑÄ¡¸ÅÇÐȸ (Á¤È¸¿ø)

±¹¿ÜÈ°µ¿

more
  • 2018 .09 .22 ~  2018 .09 .22 :  Asian Interchange in Stroke (Manila, Philippines) Management of emergency cases of patients on NOACs (invited speaker: symposium)
  • 2015 .10 .08 ~  2015 .10 .08 :  Calgary Stroke Program Academic Lecture (Calgary, Canada): Application of nanobiomaterials for stroke theragnosis. (Invited lecture)
  • 2014 .02 .12 ~  2014 .02 .14 :  International Stroke Conference 2014 (San Diego, USA): Ceria nanoparticles begin: new therapeutic nanomaterials against ischemic stroke (Invited speaker: Symposium)
  • 2018 .04 .12 ~  2018 .04 .12 :  The 27th European Stroke Conference (Athens, Greece) Anti-apoptotic and anti-inflammatory effects of sildenafil on neuronal cells and endothelial cells exposed to oxygen-glucose deprivation (Oral Presentation)
  • 2018 .04 .11 ~  2018 .04 .11 :  The 27th European Stroke Conference (Athens, Greece) Insulin resistance as a poor prognostic marker in non-diabetic ischemic stroke (Oral Presentation)
  • 2017 .10 .21 ~  2017 .10 .21 :  The 8th Japan-Korea Joint Stroke Conference (Niigata, Japan): Acute-phase brain natriuretic peptide as a marker of poor prognosis of ischemic stroke related to atrial fibrillation with preserved ejection fraction. (Oral Presentation)
  • 2016 .10 .30 ~  2016 .11 .01 :  13th International Symposium on Thrombolysis Thrombectomy and Acute Stroke Therapy (Kobe, Japan): Resistant hypertension as a poor prognosticator for acute ischemic stroke. (Oral Presentation)
  • 2015 .04 .17 ~  2015 .04 .19 :  The European Stroke Organisation Conference 2015 (Glasgow, UK): Impact of adherence with antihypertensive therapy on the mortality after ischemic stroke: a nationwide multicenter follow-up study. (Oral Presentation)
  • 2015 .02 .11 ~  2015 .02 .13 :  International Stroke Conference 2015 (Nashville, USA): Impact of adherence with antiplatelet monotherapy on the mortality after ischemic stroke: a nationwide multicenter follow-up study. (Oral Presentation)
  • 2014 .02 .12 ~  2014 .02 .14 :  International Stroke Conference 2014 (San Diego, USA): Effect of long-term treatment with fimasartan on transient focal ischemia in rat brain. (Oral Presentation)
  • 2014 .02 .12 ~  2014 .02 .14 :  International Stroke Conference 2014 (San Diego, USA): Effect of warfarin adherence on the mortality after ischemic stroke: a nationwide multicenter cohort study. (Oral Presentation)
  • 2012 .02 .01 ~  2012 .02 .03 :  International Stroke Conference 2012 (New Orleans, USA): Detrimental effect of leptin on intracerebral hemorrhage via STAT3 signal pathway. (Oral Presentation)
  • 2011 .05 .24 ~  2011 .05 .27 :  The 20th European Stroke Conference (Hamburg, Germany): A significant association of obesity with cerebral microbleeds in asymptomatic elderly subjects. (Oral Presentation)
  • 2008 .11 .21 ~  2008 .11 .23 :  The 4th Japan-Korea Joint Stroke Conference (Fukuoka, Japan): Pulse pressure is an independent predictor of white matter hyperintensities in the healthy elderly. (Oral Presentation)

»çȸȰµ¿

more
  • 2020 .09 .01 ~  2022 .08 .31 :  (ÁÖ)Á¨ÇÏÀÓ¹ÙÀÌ¿ÀÅØ CTO

³í¹®

more
  • [SCI] (Elevated Troponin Levels are Associated With Early Neurological Worsening in Ischemic Stroke with Atrial Fibrillation.)
  • [SCI] (Impact of Sleep-disordered Breathing on Functional Outcomes in Ischemic Stroke: A Cardiopulmonary Coupling Analysis.)
  • [SCI] (Incidence of oral anticoagulant interruption among stroke patients with atrial fibrillation and subsequent stroke)
  • [SCI] (Perfusion Defect is Associated with Early Ischemic Recurrence in Patients with a Transient Ischemic Attack.)
  • [SCI] (Effect of statin therapy on the outcomes of patients with acute ischemic stroke and atrial fibrillation.)
  • [SCI] (Nonarteritic Anterior Ischemic Optic Neuropathy is Associated with Cerebral Small Vessel Disease)
  • [SCI] (Characteristics and Factors for Short-Term Functional Outcome in Stroke Patients With Atrial Fibrillation, Nationwide Retrospective Cohort Study.)
  • [SCI] (Long-Term Outcomes of Real-World Korean Patients with Atrial-Fibrillation-Related Stroke and Severely Decreased.)
  • [SCI] (Baseline D-Dimer Levels as a Risk Assessment Biomarker for Recurrent Stroke in Patients with Combined Atrial Fibrillation and Atherosclerosis.)
  • [SCI] (Ceria Nanoparticles Fabricated with 6-Aminohexanoic Acid that Overcome Systemic Inflammatory Response Syndrome.)
  • [SCI] (Ceria nanoparticles synthesized with aminocaproic acid for the treatment of subarachnoid hemorrhage.)
  • [SCI] (Customized lipid-coated magnetic mesoporous silica nanoparticle doped with ceria nanoparticles for theranosis of intracerebral hemorrhage.)
  • [SCI] (Pretreatment with low-dose fimasartan ameliorates NLRP3 inflammasome-mediated neuroinflammation and brain injury after intracerebral hemorrhage.)
  • [SCI] (Contrast-Enhanced Color-Coded Doppler Sonography in Moyamoya Disease: A Retrospective Study)
  • [SCI] (Defining CT perfusion thresholds for infarction in the golden hour and with ultra-early reperfusion.)
  • [SCI] (Effect of Statins on Survival Following Stroke in Patients With Cancer.)
  • [SCI] (Temporal changes in the neutrophil to lymphocyte ratio and the neurological progression in cryptogenic stroke with active cancer)
  • [SCI] (FLAIR vascular hyperintensities predict early ischemic recurrence in TIA)
  • [SCI] (Gamma-glutamyl transferase predicts future stroke: a Korean nationwide study)
  • [SCI] (Treatment of cryptogenic stroke with active cancer with a new oral anticoagulant)
  • [SCI] (Nocturnal desaturation is associated with neurological deterioration following ischemic stroke: a retrospective observational study)
  • [SCI] (Ceria-zirconia nanoparticles as enhanced multi-antioxidant for sepsis treatment.)
  • [SCI] (Physical activity frequency and the risk of stroke: a nationwide cohort study in Korea.)
  • [SCI] (Biocompatible custom ceria nanoparticles against reactive oxygen species resolve acute inflammatory reaction after intracerebral hemorrhage)
  • [SCI] (Intravenous Thrombolysis in Acute Ischemic Stroke with Active Cancer)
  • [SCI] (Retinal vein occlusion as the surrogate marker for premature brain aging in young patients)
  • [±¹¿Ü³í¹®] (Cystatin C is a useful predictor of early neurological deterioration following ischemic stroke in elderly patients with normal renal function)
  • [SCI] (Predictors of 30-day mortality and the risk of recurrent systemic thromboembolism in cancer patients suffering acute ischemic stroke.)
  • [±¹¿Ü³í¹®] (Multimodality CT based imaging to determine clot characteristics and recanalization with intravenous tPA in patients with acute ischemic stroke.)
  • [SCI] (D-dimer as a predictor of early neurological deterioration in cryptogenic stroke with active cancer.)
  • [SCI] (Association of serum uric acid and cardioembolic stroke in patients with acute ischemic stroke.)
  • [SCI] (Cerebral small vessel disease in branch retinal artery occlusion.)
  • [±¹³»³í¹®] (Brain oxygen monitoring via jugular venous oxygen saturation in a patient with fulminant hepatic failure)
  • [SCI] (Nocturnal desaturation in the stroke unit is associated with wake-up ischemic stroke.)
  • [SCI] (Prolonged sleep increases the risk of intracerebral hemorrhage: a nationwide case-control study.)
  • [SCI] (Tachycardia burden in stroke unit is associated with functional outcome after ischemic stroke)
  • [SCI] (Anti-inflammatory effects of fimasartan via Akt, ERK, and NF¥êB pathways on astrocytes stimulated by hemolysate.)
  • [SCI] (Prognostic importance of weight change on short-term functional outcome in acute ischemic stroke.)
  • [SCI] (Effect of long-term treatment with fimasartan on transient focal ischemia in rat brain.)
  • [SCI] (Obesity-stroke paradox and initial neurological severity.)
  • [SCI] (A novel computerized clinical decision support system for treating thrombolysis in patients with acute ischemic stroke.)
  • [SCI] (Grading and interpretation of white matter hyperintensities using statistical maps.)
  • [SCI] (High serum alkaline phosphatase in relation to cerebral small vessel disease.)
  • [SCI] (Practical issues to prevent stroke associated with non-valvular atrial fibrillation.)
  • [SCI] (Paradoxical effect of obesity on hemorrhagic transformation after acute ischemic stroke.)
  • [SCI] (Effects of celecoxib on hematoma and edema volumes in primary intracerebral hemorrhage: a multicenter randomized controlled trial.)
  • [SCI] (Excessive work and risk of hemorrhagic stroke: a nationwide case-control study.)
  • [SCI] (Detrimental effects of leptin on intracerebral hemorrhage via the STAT3 signal pathway.)
  • [SCI] (Extents of white matter lesions and increased intraventricular extension of intracerebral hemorrhage.)
  • [SCI] (Serum uric acid levels and cerebral microbleeds in patients with acute ischemic stroke.)
  • [SCI] (A quantitative comparison of the vertebral artery and transverse foramen using CT angiography.)
  • [SCI] (Impact of CHADS(2) score on neurological severity and long-term outcome in atrial fibrillation-related ischemic stroke.)
  • [SCI] (Association of obesity with cerebral microbleeds in neurologically asymptomatic elderly subjects.)
  • [SCI] (Impact of smoking cessation on the risk of subarachnoid hemorrhage: a nationwide multicenter case-control study.)
  • [SCI] (Ceria nanoparticles that can protect against ischemic stroke.)
  • [SCI] (The relation between chronic kidney disease and cerebral microbleeds: difference between diabetic and non-diabetic patients.)
  • [SCI] (No significant association of aspirin use with cerebral microbleeds in the asymptomatic elderly.)
  • [SCI] (Pentraxin 3: a novel and independent prognostic marker in ischemic stroke.)
  • [SCI] (Adipocytokines and ischemic stroke: differential associations between stroke subtypes.)
  • [SCI] (Dynamic temporal change of cerebral microbleeds: long-term follow-up MRI study.)
  • [SCI] (Spontaneous carotid cavernous fistula in a case with protein S deficiency that newly developed ophthalmoplegia after embolization.)
  • [SCI] (Body mass index, initial neurological severity and long-term mortality in ischemic stroke.)
  • [SCI] (Ischemic stroke during sleep: its association with worse functional outcome.)
  • [SCI] (Elevated leukocyte count in asymptomatic subjects is associated with a higher risk for cerebral white matter lesions.)
  • [SCI] (Paradoxical longevity in obese patients with intracerebral hemorrhage.)
  • [SCI] (Advanced coronary artery calcification is associated with cerebral small vessel diseases.)
  • [SCI] (Age-independent association of pulse pressure with cerebral white matter lesions in asymptomatic elderly subjects.)
  • [SCI] (Morphine-sensitive paroxysmal sympathetic storm in pontine intracerebral hemorrhage.)
  • [SCI] (Increased serum alkaline phosphatase as a predictor of long-term mortality after stroke.)
  • [SCI] (Effects of low serum triglyceride on stroke mortality: A prospective follow-up study.)
  • [SCI] (Bilateral subthalamic deep brain stimulation in Parkinson disease patients with severe tremor.)
  • [SCI] (White matter lesions and poor outcome after intracerebral hemorrhage: a nationwide cohort study.)
  • [SCI] (Advanced coronary artery calcification is associated with ischemic stroke.)
  • [SCI] (Significant association of metabolic syndrome with silent brain infarction in elderly people.)
  • [SCI] (Carotid cavernous fistula with cervical myelopathy.)
  • [±¹³»³í¹®] (Streptococcus viridans meningitis after epidural nerve block.)
  • [±¹³»³í¹®] (Adult onset familial cherry-red spot myoclonus.)
  • [SCI] (Low level of low-density lipoprotein cholesterol increase hemorrhagic transformation in large artery atherothrombosis but not in cardioembolism.)

±âŸ

more
  • (ƯÇãµî·Ï) ÇöÅÃȯ, À̽ÂÈÆ, ¼Ò¹Î, ±èÄ¡°æ. ¼¼¸®¾Æ-Áö¸£ÄÚ´Ï¾Æ °í¿ëü ³ª³ëÀÔÀÚ¿Í ¼¼¸®¾Æ-Áö¸£ÄÚ´Ï¾Æ ³ª³ëº¹ÇÕüÀÇ ÇÕ¼º ¹× ÀÌÀÇ ÆÐÇ÷Áõ Ä¡·áÁ¦·Î¼­ÀÇ ÀÀ¿ë. Korea. KR 10-1770414, Issued on 22 Sep 2017.
  • (ƯÇãµî·Ï) À̽ÂÈÆ, ÇöÅÃȯ, ±èÄ¡°æ, °­µ¿¿Ï, ¼Ò¹Î. ¼¼¸®¾Æ ³ª³ëº¹ÇÕü¸¦ Æ÷ÇÔÇÏ´Â ºñ¿Ü»ó¼º µÎ°³³» ÃâÇ÷ Ä¡·á¿ë ¾àÇÐÀû Á¶¼º¹°. Korea. KR 10-1696903, Issued on 10 Jan 2017.
  • (ƯÇãÃâ¿ø) Hyeon T, Lee SH, Soh M, Kim CK. Synthesis of ultra-small ceriazirconia nanoparticles and ceria-zirconia nanocomplex and its application as a therapeutic agent for sepsis. United States. US 15/415,823, Filed on 5 April 2016.
  • (ƯÇãÃâ¿ø) Hyeon T, Lee SH, Kim T, Kim CK. Ceria nanocomplex, pharmaceutical composition comprising said ceria nano complex, and method for preparing same. United States and Europe. US 14/391.255, EU 13776300.9, Filed on 1 April 2013.
  • (ƯÇãÃâ¿ø) Yoon BW, Kim CK, Chi YH, Kim HK. A composition comprising the fimasartan for treating and preventing ischemic brain disease. Korea. KR 10-2013-0118792, Filed on 10 April 2013.
  • (ƯÇãÃâ¿ø) Hyeon T, Lee SH, Kim T, Kim CK. Ceria nanocomposite, pharmaceutical formulation comprising the same, and process for preparing the sames. Korea. KR 10-2012-0036880, Filed on 9 April 2012.

ÃÖÁ¾¼öÁ¤ÀÏ : 2021.11.25